Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sialorrhea × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 21 Carcinoma, Basal Cell 10 Uterine Cervical Dysplasia 7 Melanoma 6 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Precancerous Conditions 3 Glioblastoma 3 Condylomata Acuminata 3 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Non-Muscle Invasive Bladder Neoplasms 2 Keratosis 2 Hutchinson's Melanotic Freckle 2 HIV Infections 2 Glioma 2 Astrocytoma 2 Warts 1 Vulvar Neoplasms 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sialorrhea 1 Sexually Transmitted Diseases 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Satisfaction 1

Interventions

Imiquimod 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡